Opa interacting protein 5 (OIP5) was a member of cancer-testis antigen (CTA) family, which might be a novel therapeutic target for cancer therapy because of the high expression of this gene in colorectal cancer 49, lung cancer 50, and esophageal cancer 50. The gene discussed is OIP5; the disease is esophageal cancer.